Insights

Strategic funding The company recently closed a $175M Series D led by Boston Scientific, signaling strong investor confidence and potential for strategic partnerships and co-development opportunities with major players in structural heart disease.

Clinical focus Focused on minimally invasive transcatheter therapies for mitral regurgitation with a pathway to tricuspid regurgitation, presenting a growing pipeline and expansion potential for physicians and hospital systems adopting innovative structural heart solutions.

Market momentum Active funding and leadership changes in 2022 alongside sustained R&D around AltaValve position the company for accelerated commercialization, inviting outreach to high-volume cardiology centers and valve clinics seeking new MR treatment options.

Strategic partnerships Boston Scientific involvement in the latest financing suggests opportunities for collaboration, distribution, or co-development deals with a leading interventional device company to scale adoption and reach.

Customer base readiness Revenue range indicates commercial activity and hospital demand for novel MR therapies; target multi-hospital health systems, academic centers, and cardio-thoracic surgeons as potential early adopters and top-of-funnel champions.

4C Medical Technologies, Inc. Tech Stack

4C Medical Technologies, Inc. uses 8 technology products and services including Webpack, Microsoft 365, Google Fonts API, and more. Explore 4C Medical Technologies, Inc.'s tech stack below.

Webpack

Development

Microsoft 365

Google Fonts API

Font Scripts

JSON-LD

Javascript Frameworks

Stimulus

Javascript Frameworks

jQuery

Javascript Libraries

SiteGround

Platform As A Service

Sitelinks Search Box

Web Tools And Plugins

4C Medical Technologies, Inc. Email Formats	Example	Percentage
FLast@4cmed.com	JDoe@4cmed.com	100%

4C Medical Technologies, Inc. Email Formats

Example

Percentage

FLast@4cmed.com

JDoe@4cmed.com

100%

Frequently Asked Questions

What is 4C Medical Technologies, Inc.'s official website and social media links?

4C Medical Technologies, Inc.'s official website is 4cmed.com and has social profiles on LinkedIn Crunchbase.

How much revenue does 4C Medical Technologies, Inc. generate?

As of July 2026, 4C Medical Technologies, Inc.'s annual revenue is estimated to be $25M - $50M.

What is 4C Medical Technologies, Inc.'s SIC code NAICS code?

4C Medical Technologies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 4C Medical Technologies, Inc. have currently?

As of July 2026, 4C Medical Technologies, Inc. has approximately 62 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Of Therapy Development: A. G.Senior Executive Vice President: K. K.Sr. Manager: J. A.. Explore 4C Medical Technologies, Inc.'s employee directory with LeadIQ.

What industry does 4C Medical Technologies, Inc. belong to?

4C Medical Technologies, Inc. operates in the Biotechnology Research industry.

What technology does 4C Medical Technologies, Inc. use?

4C Medical Technologies, Inc.'s tech stack includes WebpackMicrosoft 365Google Fonts APIJSON-LDStimulusjQuerySiteGroundSitelinks Search Box.

What is 4C Medical Technologies, Inc.'s email format?

4C Medical Technologies, Inc.'s email format typically follows the pattern of FLast@4cmed.com. Find more 4C Medical Technologies, Inc. email formats with LeadIQ.

How much funding has 4C Medical Technologies, Inc. raised to date?

As of July 2026, 4C Medical Technologies, Inc. has raised $175M in funding. for $175M.

When was 4C Medical Technologies, Inc. founded?

4C Medical Technologies, Inc. was founded in 2016.

4C Medical Technologies, Inc.

Q: What technology does 4C Medical Technologies, Inc. use?

4C Medical Technologies, Inc.'s tech stack includes JSON-LD, X-Content-Type-Options, Webpack, HSTS, Google Fonts API.

Q: How much funding has 4C Medical Technologies, Inc. raised to date?

4C Medical Technologies, Inc. has raised $175M in funding for $175M.

Q: What is 4C Medical Technologies, Inc.'s NAICS code?

4C Medical Technologies, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMinnesota, United States51-200 Employees

4C Medical Technologies, Inc. is a biotechnology-driven medical device company focused on minimally invasive therapies for structural heart disease. Its approach to mitral regurgitation uses a transcatheter device positioned supra annularly to stop leakage from the left atrium, with atrial-only fixation designed to minimize disruption to the left ventricle and related structures. The company aims to address MR without replacing the native valve, with plans to extend the method to tricuspid regurgitation.

Headquartered in Maple Grove, Minnesota, the firm operates as a mid-sized player in the biotechnology research space. It has historical work around the AltaValve transcatheter mitral valve replacement platform, reflecting its broader focus on percutaneous solutions for structural heart disease.

Insights

Similar companies to 4C Medical Technologies, Inc.

Icagen

Edwards Lifesciences

LivaNova

Abbott

Penumbra

Cardinal Health

Medtronic

Boston Scientific